The battle against COVID-19 took a major step forward yesterday, as the U.S. moved closer to distributing the first one-shot COVID-19 vaccine, after an independent expert advisory panel recommended drug regulators authorized the Johnson & Johnson vaccine for emergency use, The Guardian website reports today (February 27, 2021).
The authorization would be a significant boost to the Biden administration's vaccination plans, making Johnson & Johnson's vaccine the third available to the public. Johnson & Johnson told a congressional hearing this week that it expects to deliver 20 million doses by March and a total of 100 million doses before the end of June.
Johnson & Johnson vaccine -- along with Pfizer and Moderna -- should provide the U.S. with more than enough supply to vaccinate every vaccine-eligible person.
No comments:
Post a Comment